Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Operating Expenses: 2012-2024

Historic Operating Expenses for Neurogene (NGNE) over the last 11 years, with Dec 2024 value amounting to $83.5 million.

  • Neurogene's Operating Expenses rose 7.29% to $23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.3 million, marking a year-over-year increase of 26.79%. This contributed to the annual value of $83.5 million for FY2024, which is 50.28% up from last year.
  • Neurogene's Operating Expenses amounted to $83.5 million in FY2024, which was up 50.28% from $55.6 million recorded in FY2023.
  • In the past 5 years, Neurogene's Operating Expenses registered a high of $83.5 million during FY2024, and its lowest value of $55.6 million during FY2023.
  • Its 3-year average for Operating Expenses is $65.2 million, with a median of $56.5 million in 2022.
  • As far as peak fluctuations go, Neurogene's Operating Expenses decreased by 1.65% in 2023, and later spiked by 50.28% in 2024.
  • Over the past 3 years, Neurogene's Operating Expenses (Yearly) stood at $56.5 million in 2022, then dropped by 1.65% to $55.6 million in 2023, then spiked by 50.28% to $83.5 million in 2024.